The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease
about
A maternal vaccine against group B Streptococcus: past, present, and futureGroup B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesMulticenter clinical evaluation of the Xpert GBS LB assay for detection of group B Streptococcus in prenatal screening specimensChallenges in reducing group B Streptococcus disease in African settings.Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at deliveryIntrapartum antibiotics and childhood atopic dermatitis.Interpretation of 2002 Centers for Disease Control guidelines for group B streptococcus and evolving provider practice patternsCompliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988.Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections.Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South AfricaAdherence to perinatal group B streptococcal prevention guidelines.Group B Streptococci serotype distribution in pregnant women in Ghana: assessment of potential coverage through future vaccines.Group B streptococcus antimicrobial resistance in neonates born to group B streptococcus-colonized mothers: Single-center survey.Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999.A 5-Day-Old Late Preterm Infant With GBS Disease Despite Adequate Intrapartum Prophylaxis: Early or Late-Onset Disease?Evaluation of an in-house real-time polymerase chain reaction method to identify group B streptococcus colonization in pregnancy.Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study.Vaginal group B streptococcus status during intrapartum antibiotic prophylaxis.Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis.A GBS culture collected shortly after GBS prophylaxis may be inaccurate.Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.Intrapartum test for detection of Group B Streptococcus colonization during labor.Evaluation of the sensitivity of a rapid polymerase chain reaction for detection of group B streptococcus.
P2860
Q26822039-B841C2B7-7FFF-4A5F-96F4-41C323B2E2F9Q28075884-50B04A23-D3A2-4F52-8F35-4923FE827226Q28251830-39BA53F4-2F99-412C-B11B-CC3B35E80248Q30241490-CFC84513-6DD0-46BA-BD1D-699772B01A26Q35131152-2BE57B63-8BBB-41EC-A198-36F828EE21E5Q35151156-0E268BF5-4C70-4CC7-80FF-5A1625E93A56Q35574994-AB059397-E4BF-4CCD-A667-AE55E5F168F7Q35751149-1BF5B1D1-1FEC-47F2-A536-44E026477652Q35836791-C599C617-0E74-4AE9-B332-34AA991E3DECQ36432173-4DBC6102-F5C3-4AD4-85F1-50A2D4EA246FQ36763507-9417437A-D291-4C59-A790-955930837A20Q37036271-0FFC0FD8-ACB9-4A7C-B19A-99A7253FECE8Q37173310-F2FA74F3-88A0-46C8-B35D-5D3751F69078Q38973082-72D268E4-DF29-482A-BE4C-F50300A71995Q39455666-CC003D41-3E29-401F-A956-263D327DE3A2Q40581083-8B2A14E6-9F79-46C2-AAEE-4BC8B415E022Q41087040-974798AE-433A-4994-B2A6-E7446E059203Q41199614-6FDF3A47-834E-4637-B7FC-897B340F5A52Q41250825-CDE9F7E8-073F-43EC-819A-1AB1D35995A0Q41551757-4DC4E088-051D-4B3A-B93E-8EEC3B65173DQ42257745-9823E59F-7757-4080-8C64-65520E5686BEQ44128582-3488CAD6-32E2-43F5-B41D-D6988A719E71Q44503294-54E05B6B-E43D-45A2-8B29-098954EB7E74Q50501325-817265E1-A4C1-4C56-BDFC-CA089D1F5561Q54187968-B3D5D7E9-C46E-4ABB-BD19-1156CFB91990
P2860
The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease
description
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Mai 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: May 2001)
@en
vedecký článok (publikovaný 2001-05)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001-05)
@nl
наукова стаття, опублікована в травні 2001
@uk
مقالة علمية (نشرت في مايو 2001)
@ar
name
The effectiveness of risk-base ...... group B streptococcal disease
@ast
The effectiveness of risk-base ...... group B streptococcal disease
@en
The effectiveness of risk-base ...... group B streptococcal disease
@nl
type
label
The effectiveness of risk-base ...... group B streptococcal disease
@ast
The effectiveness of risk-base ...... group B streptococcal disease
@en
The effectiveness of risk-base ...... group B streptococcal disease
@nl
prefLabel
The effectiveness of risk-base ...... group B streptococcal disease
@ast
The effectiveness of risk-base ...... group B streptococcal disease
@en
The effectiveness of risk-base ...... group B streptococcal disease
@nl
P2093
P3181
P356
P1476
The effectiveness of risk-base ...... group B streptococcal disease
@en
P2093
G G Rhoads
J B Philips
J D Clemens
L E Weisman
R A Brenner
P304
P3181
P356
10.1067/MOB.2001.113875
P407
P577
2001-05-01T00:00:00Z